Galectin Therapeutics, Inc. Skyrocketed
Fri, Jul 09, 2021 at 05:30 PM
Galectin Therapeutics, Inc. (GALT:NASDAQ) rocketted at $3.45, representing a gain of 25%. On Thu, Jul 08, 2021, GALT:NASDAQ hit a New 2-Week Low of $2.76. The stock got featured on our News Catalysts scanner on Fri, Jul 09, 2021 at 01:34 PM in the 'BIOTECH' category. From Thu, Jun 24, 2021, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Thu, Apr 29, 2021 at $5.7 with a volume of 8M+, and its share price has been moving sideways in recent weeks.
About Galectin Therapeutics, Inc. (GALT:NASDAQ)
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Top 10 Gainers:
- SGOCO Group, Ltd. (SGOC:NASDAQ), 279.46%
- Stamps.com Inc. (STMP:NASDAQ), 63.98%
- TPST (TPST:NASDAQ), 49.38%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 45.75%
- UTStarcom Holdings Corp. (UTSI:NASDAQ), 29.8%
- LHDX (LHDX:NASDAQ), 29.18%
- Mer Telemanagement Solutions Ltd. (MTSL:NASDAQ), 26.4%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 25%
- AGRI (AGRI:NASDAQ), 21.48%
- Carver Bancorp, Inc. (CARV:NASDAQ), 21.06%